GALMED PHARMACEUTICALS LTD's ticker is GLMD and the CUSIP is M47238106. A total of 34 filers reported holding GALMED PHARMACEUTICALS LTD in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $11,590 | +89053.8% | 27,177 | 0.0% | 0.00% | – |
| Q4 2022 | $13 | -99.8% | 27,177 | 0.0% | 0.00% | – |
| Q3 2022 | $8,000 | -55.6% | 27,177 | 0.0% | 0.00% | – |
| Q2 2022 | $18,000 | -58.1% | 27,177 | 0.0% | 0.00% | – |
| Q1 2022 | $43,000 | -12.2% | 27,177 | 0.0% | 0.00% | – |
| Q4 2021 | $49,000 | -34.7% | 27,177 | 0.0% | 0.00% | – |
| Q3 2021 | $75,000 | +25.0% | 27,177 | +36.2% | 0.00% | – |
| Q2 2021 | $60,000 | -11.8% | 19,960 | 0.0% | 0.00% | – |
| Q1 2021 | $68,000 | +9.7% | 19,960 | 0.0% | 0.00% | – |
| Q4 2020 | $62,000 | -11.4% | 19,960 | 0.0% | 0.00% | – |
| Q3 2020 | $70,000 | -26.3% | 19,960 | 0.0% | 0.00% | – |
| Q2 2020 | $95,000 | +37.7% | 19,960 | 0.0% | 0.00% | – |
| Q1 2020 | $69,000 | -70.0% | 19,960 | -50.0% | 0.00% | – |
| Q4 2019 | $230,000 | +142.1% | 39,920 | +100.0% | 0.00% | – |
| Q3 2019 | $95,000 | -34.9% | 19,960 | 0.0% | 0.00% | – |
| Q2 2019 | $146,000 | +2.8% | 19,960 | +14.7% | 0.00% | – |
| Q1 2019 | $142,000 | -11.2% | 17,397 | -25.9% | 0.00% | – |
| Q4 2018 | $160,000 | +0.6% | 23,492 | +100.0% | 0.00% | – |
| Q3 2018 | $159,000 | +14.4% | 11,746 | 0.0% | 0.00% | – |
| Q2 2018 | $139,000 | -37.7% | 11,746 | -60.0% | 0.00% | – |
| Q4 2015 | $223,000 | +10.4% | 29,374 | +7.7% | 0.00% | – |
| Q3 2015 | $202,000 | -26.0% | 27,269 | +0.3% | 0.00% | – |
| Q2 2015 | $273,000 | +7.1% | 27,177 | +0.2% | 0.00% | – |
| Q1 2015 | $255,000 | +121.7% | 27,131 | +36.0% | 0.00% | – |
| Q4 2014 | $115,000 | -32.4% | 19,955 | +0.7% | 0.00% | – |
| Q3 2014 | $170,000 | +9.0% | 19,817 | +23.3% | 0.00% | – |
| Q2 2014 | $156,000 | – | 16,077 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|